Canada
· Delayed Price · Currency is CAD Blueberries Medical Statistics
Total Valuation
Blueberries Medical has a market cap or net worth of CAD 5.99 million. The enterprise value is 5.75 million.
| Market Cap | 5.99M |
| Enterprise Value | 5.75M |
Important Dates
The last earnings date was Wednesday, November 27, 2024.
| Earnings Date | Nov 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Blueberries Medical has 399.03 million shares outstanding. The number of shares has increased by 69.16% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 399.03M |
| Shares Change (YoY) | +69.16% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.66% |
| Owned by Institutions (%) | n/a |
| Float | 152.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 20.03 |
| PB Ratio | 4.86 |
| P/TBV Ratio | 4.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.04 |
| EV / Sales | 21.62 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -7.40 |
Financial Position
The company has a current ratio of 3.09, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.09 |
| Quick Ratio | 1.22 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -132.56% and return on invested capital (ROIC) is -42.16%.
| Return on Equity (ROE) | -132.56% |
| Return on Assets (ROA) | -32.18% |
| Return on Capital (ROIC) | -42.16% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.12 |
| Inventory Turnover | 0.64 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 2.00 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 48.60 |
| Average Volume (20 Days) | 8,549 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Blueberries Medical had revenue of CAD 265,809 and -1.14 million in losses. Loss per share was -0.00.
| Revenue | 265,809 |
| Gross Profit | 133,363 |
| Operating Income | -1.12M |
| Pretax Income | -1.14M |
| Net Income | -1.14M |
| EBITDA | -1.01M |
| EBIT | -1.12M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 251,305 in cash and 11,706 in debt, giving a net cash position of 239,599 or 0.00 per share.
| Cash & Cash Equivalents | 251,305 |
| Total Debt | 11,706 |
| Net Cash | 239,599 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 1.23M |
| Book Value Per Share | 0.00 |
| Working Capital | 909,043 |
Cash Flow
In the last 12 months, operating cash flow was -775,524 and capital expenditures -491, giving a free cash flow of -776,015.
| Operating Cash Flow | -775,524 |
| Capital Expenditures | -491 |
| Free Cash Flow | -776,015 |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | 50.17% |
| Operating Margin | -423.03% |
| Pretax Margin | -429.09% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Blueberries Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -69.16% |
| Shareholder Yield | -69.16% |
| Earnings Yield | -21.43% |
| FCF Yield | -12.97% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Blueberries Medical has an Altman Z-Score of -14.09. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -14.09 |
| Piotroski F-Score | n/a |